Establishment of methodology for carrying out joint detection on bacterial genus genes and toxin genes of clostridium difficile by using TaqMan-MGB probe real-time fluorescent quantitative PCR (polymerase chain reaction) technology
A Clostridium difficile and gene technology, which is applied in the field of TaqMan-MGB probe real-time fluorescence quantitative PCR technology combined detection of Clostridium difficile gene and toxin genetics, which can solve the problem of serious harm, high incidence rate, and resistance to clinical departments. high drug problem
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0006] 1. Gene bank search, sequence comparison, and screening of specific sequences
[0007] 2. Design probes and primers.
[0008] 3. Optimize the reaction conditions.
[0009] 4. Concentration preparation of various reagents in the PCR reaction system.
[0010] 5. Verify the established TaqMan / MGB probe PCR technology, and evaluate the detection method from the aspects of detection specificity, sensitivity and anti-interference.
[0011] 6. Through the identification of Clostridium difficile genus and screening of toxin carrying status in the feces of patients with clinically unknown diarrhea patients, compared with the traditional enzyme immunological method for genus identification and toxin detection, the accuracy and advantages of the patent of the present invention were evaluated.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com